BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 19, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

BioWorld MedTech’s Diagnostics Extra for Feb. 18, 2021

Feb. 18, 2021
By Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: Urine offers early clues to cancer, Improving detection of esophageal cancer; PanFAM-1 study nears completion.
Read More
Hand holding FDA blocks

Missing data, lack of operator blinding among issues that sidetrack Lutonix PMA

Feb. 17, 2021
By Mark McCarty
A U.S. FDA advisory committee voted 14 nays to three ayes that the benefits of the Lutonix 014 drug-coated balloon (DCB) do not outweigh the risks in a panel proceeding peppered by problems with missing data and a lack of operator blinding. The panel widely saw the use of paclitaxel-eluting technologies in other areas of the vasculature as a reassurance that this device might perform as promised, but the outcome nonetheless leaves the sponsor with a new round of negotiations with the FDA as to how to move forward.
Read More
Person in hospital scrubs uses Snapshot

Kent’s deal with Net Health to expand Snapshot’s footprint

Feb. 17, 2021
By David Godkin
TORONTO – Think of it. More than 14,000 facilities boasting 98% of the largest hospital chains across the U.S., two-thirds of skilled nursing facilities and hospice organizations and doctors’ offices. It’s that broad customer base Kent Imaging Inc. will have access to following its Jan. 26 agreement with medical software and analytics giant Net Health Inc., helping to expand the footprint of Kent Imaging’s Snapshot device for assessing non-healing wounds, notably those arising from diabetes.
Read More
Going public ticker

Humacyte charts IPO via merger with special purpose acquisition company

Feb. 17, 2021
By Meg Bryant
Humacyte Inc., which develops universally implantable, bioengineered human tissue at commercial scale, has agreed to go public via a merger with Alpha Healthcare Acquisition Corp. (AHAC), a blank-check company led by Rajiv Shukla. Upon closing of the deal, AHAC will be renamed Humacyte Inc. and will be led by Humacyte’s current CEO, Laura Niklason. The combined company’s stock is expected to list on the Nasdaq Capital Market under the ticker symbol HUMA.
Read More
Researcher and trial participant

AI-powered brain implant improves post-stroke mobility

Feb. 17, 2021
By Annette Boyle
Researchers at Thomas Jefferson University have implanted brain electrodes in a patient who suffered a subcortical ischemic stroke more than a year ago to help them overcome abnormal muscle tone and control a robotic arm brace. Artificial intelligence (AI) algorithms interpret neuronal signals recorded by the electrodes into movement of the brace.
Read More
3D heart in chest

Rsip Vision develops AI-based coronary artery segmentation tool

Feb. 17, 2021
By David Ho
HONG KONG – Rsip Vision Ltd. have developed a new coronary artery segmentation tool based on deep learning technology that should allow for faster 3D models of coronary artery anatomy and facilitate precise measurements of artery length and diameter.
Read More

Regulatory front for Feb. 17, 2021

Feb. 17, 2021
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: HHS commits more funds for testing, materials to fight pandemic; Medtronic announces recall of Valiant Navion; Florida man pleads guilty in DME fraud.
Read More

Regulatory actions for Feb. 17, 2021

Feb. 17, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Delta International Services & Logistics, Everlywell, Horiba Medical, Thermo Fisher Scientific, Vax-Immune Diagnostics.
Read More

Other news to note for Feb. 17, 2021

Feb. 17, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocorp, Bionic Vision Technologies, Dental Fix Canada, Endra Life Sciences, Ginserv, Goetze Dental, Health2sync, Inspira, Midwest Dental Equipment & Supply, Milestone Scientific, Natera, Personalis, Progenity, Scott’s Dental, Smiths Detection, Socialdiabetes, Teleflex, Theragnostics, Thermo Fisher, Vipergen, Vitalhub.
Read More

In the clinic for Feb. 17, 2021

Feb. 17, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaconda Biomed, Catalyst Orthoscience, Genmark Diagnostics, Vocalis Health.
Read More
Previous 1 2 … 1266 1267 1268 1269 1270 1271 1272 1273 1274 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 18, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Doctor with brain illustration, businessman with dollar sign illustration

    Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

    BioWorld
    Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
  • Illustration of tau accumulating in a neuron cell.

    Biogen AD drug shows tau, cognition benefit, despite trial miss

    BioWorld
    Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing